About us

Meletios Therapeutics SAS

RCS Lyon 883 003 691
Share capital 3201,20€

24 rue Jean Baldassini
69007 Lyon

13 rue Monsigny 
75002 Paris

Editor of the website

Chloé Colarossi


Editorial board

Catherine Martre, CEO

Hosting of the website

SAS au capital social de 140 883,49 €
RCS Paris B 847 727 914
Code APE : 7010Z
N° TVA : FR21847727914
Siège social : 63 BD MASSENA 75013 PARIS

You can visit their privacy policy following this link : https://www.gandi.net/fr/contracts/privacy-policy

Privacy Policy

Your privacy is important to us. It is Meletios Therapeutics’ policy to respect your privacy and comply with any applicable law and regulation regarding any personal information we may collect about you, including across our website, https://meletiostx.com.

This policy is effective as of 16 April 2021 and was last updated on 21 June 2021.

Use of Cookies

We use “cookies” to collect information about you and your activity across our site. A cookie is a small piece of data that our website stores on your computer, and accesses each time you visit, so we can improve your experience on our website.

Limits of Our Policy

Our website may link to external sites that are not operated by us. Please be aware that we have no control over the content and policies of those sites and cannot accept responsibility or liability for their respective privacy practices.

Changes to This Policy

At our discretion, we may change our privacy policy to reflect updates to our business processes, current acceptable practices, or legislative or regulatory changes. If we decide to change this privacy policy, we will post the changes here at the same link by which you are accessing this privacy policy.

If required by law, we will get your permission or give you the opportunity to opt in to or opt out of, as applicable, any new uses of your personal information.

Contact Us

For any questions or concerns regarding your privacy, you may contact us using the following details: